MTOR and tuberous sclerosis: Moreover, clinical trials are also in process to examine the effect of mTOR inhibitors such as sirolimus on preventing and delaying the onset of seizures and possibly IESS in infants with TSC (Clinical Trial Gov, NCT05104983).